Event Schedule

Have a look at Schedule

08:00 - 08:50

Registration & Itinerary Collection

08:50 - 09:00

Chairperson Welcome Address

World BI

Leo Kirkovsky

Sr. Director

exelixis
09:00

Keynote Presentation 1: The World Is Changing, We Must Adapt

World BI

Hong Cheng

VP, Head of Research Strategy

Sanofi

Emerging Trends in Oncology

9:25

Presentation 2: Botanical drugs for cancer therapeutics

World BI

Igor Nasonkin

Founder, CEO & Chief Scientific Officer

Phythera Therapeutics, Inc
9:50

Presentation 3: Next Generation RNA-Based Therapeutics in Oncology: Current Progress & Future Prospects

World BI

Dinesh Chandra

Independent Biotech Consultant

Johnson & Johnson (Former)
10:15

Coffee Break & Networking Session

Fragment Based Drug Discovery

11:05

Presentation 4: Recent results from massively multitask Profile-QSAR models as accurate as 4-point IC50s for 9000 assays

World BI

Eric Martin

Director of Computational Chemistry

Novartis
11:30

Presentation 5: MolecuLernTM Driven Deep Learning Empirical Models In Fragment-Based Design and Development of Small Molecules and Degraders Targeting (un)Druggable Protein Targets

World BI

Hariprasad Vankayalapati, M. Pharm., PhD

Chief Scientific Officer

Biolexis Therapeutics, Inc.
11:55

Data Driven Presentation: Applying gut-derived organoids to drug discovery

World BI

Linda A. Lieberman

Head of Mucosal Biology Research, Discovery Immunology

Merck Research Laboratories
12:20

Networking Lunch

Drug Development Innovations

13:20

Case Study Presentation: In vitro/vivo Evaluation of an Ultra-potent Rifampicin Based Antibiotic

World BI

Dr. Thomas Nittoli

Senior Director, R&D Chemistry

Regeneron Pharmaceuticals, Inc
13:45

Presentation 6: Engineering Proteolysis-Targeting Antibodies (PROTABs) for degradation of cell surface receptors

World BI

Yee Seir (Sheil) Kee

Scientist III

Genentech
14:10

Case Study Presentation: Designing Therapies with Nature's Codebook: Human Genetics

World BI

Karol Estrada

VP Translational Genomics

Maze Therapeutics
14:35

Deep Dive Presentation: Collaborative Approaches in Drug Development:

  • Showcasing successful collaborations between industry and academia. Discussing the role of partnerships in driving innovation in drug discovery
World BI

Ekundayo Osimboni, MBA, PMP

Sr. Director, Strategic Alliance & Partnership Management

Foghorn Therapeutics Inc
15:00

Keynote Presentation: Optimizing Drug Development Strategies Across Therapeutic Areas: Insights from Clinical Pharmacology and Translational Research

World BI

Alan Xiao

CSO, Sr Consultant

StarDecisis
15:25

Collaborative Conversation: Case Studies and Success Stories:

  • Real-world examples of successful drug discoveries.
  • Lessons learned and best practices.

Moderator:-

World BI

Dr. Thomas Nittoli

Senior Director, R&D Chemistry

Regeneron Pharmaceuticals, Inc

Panelists:-

World BI

Hariprasad Vankayalapati, M. Pharm., PhD

Chief Scientific Officer

Biolexis Therapeutics, Inc.
World BI

Dinesh Chandra

Independent Biotech Consultant

Johnson & Johnson (Former)
16:00

Chair Closing Remarks

World BI

Leo Kirkovsky

Sr. Director

exelixis
16:05

Happy Hours Networking

08:00 - 08:50

Registration & Itinerary Collection

08:50 - 09:00

Chair Welcome Address

World BI

Leo Kirkovsky

Sr. Director

exelixis

Development of Next Gen Therapeutics

9:00

Presentation 7: Unlocking polypharmacological profiles of drugs to innovate for new drug design

World BI

Julie Owen

Director of Chemistry

Recursion
9:25

Presentation 8: From Genes to Therapies: Multi-omic approaches in Oncology extra cellular target discovery

World BI

Satyajit Rajapurkar

Investigator

GSK
9:50

Data Driven Presentation: Development of Exercise Mimetics for Treatment of Obesity

World BI

Thomas Burris

Director of University of Florida Genetics Institute and Dean's Professor || Scientific Co-Founder

Pelagos Therapeutics
10:15

Coffee Break & Networking Session

AI & ML

11:05

Presentation 9: Artificial Intelligence-driven Target and Antibody Therapeutics Discovery from Human Sequencing Data

World BI

Xingfeng Bao

VP, Head of Biology

GV20 Therapeutics
11:30

Case Study Presentation: Combining DNA Encoded library screening and machine learning to accelerate molecule drug discovery

World BI

G. Joseph Franklin

Senior Vice President and Head of Early Discovery

Anagenex
11:55

Presentation 10: Streamlining Drug Development with Integrated Labs, Automation, and Machine Learning

World BI

Ilja Kuesters

Associate Director

Generate: Biomedicines
12:20

Case Study Presentation: Accelerating Oncology Drug Discovery with AI/ML: Predicting Protein-Ligand Binding Using Generative Models

World BI

Sai Krishna Sirumalla

Research Scientist, Machine Learning

Iambic
12:45

Lunch Break

13:45

Deep Dive Presentation: ML-based approaches for multi-parameter optimization of protein therapeutics

World BI

Tate Tabtieng

Senior Scientist

Generate Biomedicines

Synergies in Drug Innovation:

14:10

Presentation 11: Reprogramming Protein Targets for Therapeutic Benefit

World BI

Alexandra Joseph

Executive Vice President Biology

Exo Therapeutics
14:35

Presentation 12: The Naturopathic Treatment of Cancer and Chronic Diseases with immunotherapy via Immunomodulation

World BI

Eric Scheinbart M.D.

MD

Intlmed
15:00

Interactive Panel: Harnessing Artificial Intelligence in Drug Discovery: Strategies, Challenges, and Future Directions

Moderator:-

World BI

Istvan Enyedy

Senior Principal Scientist

UCB

Panelists:-

World BI

Ilja Kuesters

Associate Director

Generate: Biomedicines
World BI

Xingfeng Bao

VP, Head of Biology

GV20 Therapeutics
World BI

Alexandra Joseph

Executive Vice President Biology

Exo Therapeutics
World BI

G. Joseph Franklin

Senior Vice President and Head of Early Discovery

Anagenex
15:45

Chair Closing Remarks

World BI

Leo Kirkovsky

Sr. Director

exelixis
15:50

End of Day 2